Press release
Leading Companies Enhancing Their Presence in the Antibody Contract Manufacturing Market
The antibody contract manufacturing market is on the brink of substantial growth, driven by advancements in biologics and increasing demand for efficient production methods. With the pharmaceutical industry evolving rapidly, this sector is set to play a crucial role in meeting the needs of next-generation therapies and personalized medicine. Let's explore the anticipated market expansion, key players, notable trends, and the main segments shaping this dynamic industry.Antibody Contract Manufacturing Market Size and Growth Outlook
The antibody contract manufacturing market is projected to grow significantly, reaching a value of $34.72 billion by 2030. This expansion corresponds to a compound annual growth rate (CAGR) of 15.8% throughout the forecast period. Factors propelling this growth include a rising need for large-scale commercial antibody production, heightened investments in innovative biologic drugs, a stronger emphasis on cost-effective manufacturing approaches, the broadening pipeline of personalized medicines, and an increase in regulatory approvals for antibody treatments. Key trends influencing the market include the scaling up of manufacturing capacities, greater use of single-use bioprocessing technologies, growing demand for bispecific antibodies and antibody-drug conjugates (ADCs), a focus on manufacturing flexibility and scalability, and stringent attention to regulatory compliance and quality assurance.
Download a free sample of the antibody contract manufacturing market report:
https://www.thebusinessresearchcompany.com/report/antibody-contract-manufacturing-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
Companies Leading the Antibody Contract Manufacturing Market
Several major organizations are prominent players in the antibody contract manufacturing space. Among them are Lonza Group AG, Catalent Inc, Samsung Biologics Co Ltd, Wuxi Biologics Cayman Inc, Thermo Fisher Scientific Inc, Boehringer Ingelheim BioXcellence, AGC Biologics, and FUJIFILM Diosynth Biotechnologies. Additional important participants include AbbVie Inc, Charles River Laboratories International Inc, mAbxience, KBI Biopharma Inc, Abzena Ltd, Just-Evotec Biologics, Northway Biotech, Cerbios-Pharma, Scorpius BioManufacturing, Lotte Biologics, Rentschler Biopharma SE, Cytiva (Life Sciences CDMO), Xcellon Biologics, Celonic AG, and Syngene International Ltd.
Strategic Moves Enhancing Market Presence
In a significant development during September 2024, Agilent Technologies, a US-based supplier of laboratory technologies and services, acquired BIOVECTRA for an undisclosed amount. This acquisition aims to strengthen Agilent's contract development and manufacturing capabilities, expand its portfolio in biologics and targeted therapies, and support cutting-edge modalities such as gene editing. BIOVECTRA, headquartered in Canada, specializes in contract development and manufacturing services (CDMO) for biologics, highly potent active pharmaceutical ingredients, and molecules used in targeted therapeutics.
The antibody contract manufacturing market is on the brink of substantial growth, driven by advancements in biologics and increasing demand for efficient production methods. With the pharmaceutical industry evolving rapidly, this sector is set to play a crucial role in meeting the needs of next-generation therapies and personalized medicine. Let's explore the anticipated market expansion, key players, notable trends, and the main segments shaping this dynamic industry.
Antibody Contract Manufacturing Market Size and Growth Outlook
The antibody contract manufacturing market is projected to grow significantly, reaching a value of $34.72 billion by 2030. This expansion corresponds to a compound annual growth rate (CAGR) of 15.8% throughout the forecast period. Factors propelling this growth include a rising need for large-scale commercial antibody production, heightened investments in innovative biologic drugs, a stronger emphasis on cost-effective manufacturing approaches, the broadening pipeline of personalized medicines, and an increase in regulatory approvals for antibody treatments. Key trends influencing the market include the scaling up of manufacturing capacities, greater use of single-use bioprocessing technologies, growing demand for bispecific antibodies and antibody-drug conjugates (ADCs), a focus on manufacturing flexibility and scalability, and stringent attention to regulatory compliance and quality assurance.
Download a free sample of the antibody contract manufacturing market report:
https://www.thebusinessresearchcompany.com/report/antibody-contract-manufacturing-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
Companies Leading the Antibody Contract Manufacturing Market
Several major organizations are prominent players in the antibody contract manufacturing space. Among them are Lonza Group AG, Catalent Inc, Samsung Biologics Co Ltd, Wuxi Biologics Cayman Inc, Thermo Fisher Scientific Inc, Boehringer Ingelheim BioXcellence, AGC Biologics, and FUJIFILM Diosynth Biotechnologies. Additional important participants include AbbVie Inc, Charles River Laboratories International Inc, mAbxience, KBI Biopharma Inc, Abzena Ltd, Just-Evotec Biologics, Northway Biotech, Cerbios-Pharma, Scorpius BioManufacturing, Lotte Biologics, Rentschler Biopharma SE, Cytiva (Life Sciences CDMO), Xcellon Biologics, Celonic AG, and Syngene International Ltd.
Strategic Moves Enhancing Market Presence
In a significant development during September 2024, Agilent Technologies, a US-based supplier of laboratory technologies and services, acquired BIOVECTRA for an undisclosed amount. This acquisition aims to strengthen Agilent's contract development and manufacturing capabilities, expand its portfolio in biologics and targeted therapies, and support cutting-edge modalities such as gene editing. BIOVECTRA, headquartered in Canada, specializes in contract development and manufacturing services (CDMO) for biologics, highly potent active pharmaceutical ingredients, and molecules used in targeted therapeutics.
Emerging Trends Highlighting Innovation in Antibody Contract Manufacturing
Leading companies in this market are focusing on innovative technologies to boost efficiency and flexibility in antibody production. There is a growing shift towards adopting advanced single-use bioprocessing systems, which help reduce contamination risk and lower costs. Additionally, the rising demand for bispecific antibodies and antibody-drug conjugates (ADCs) is prompting manufacturers to develop more specialized, scalable, and adaptable production models. Enhanced regulatory compliance and quality control measures are also becoming central to market practices, ensuring product safety and effectiveness.
Additional Developments in Related Assistive Technologies
Parallel to antibody manufacturing advancements, companies within the augmentative and alternative communication (AAC) devices market are making strides by introducing sophisticated input technologies such as touch, eye-gaze, and synthetic voice systems. These innovations enable individuals with complex disabilities to communicate more naturally and independently. For example, in July 2023, Dynavox Group AB (publ), a US-based assistive tech firm, partnered with the Team Gleason Foundation to co-develop communication aids designed for people with progressive speech loss. These developments aim to broaden access to personalized communication tools in clinical, educational, and home environments.
Key Segments Driving Growth in the Antibody Contract Manufacturing Market
This market is segmented into several categories that reflect its diverse applications and users:
1) Product Types: Monoclonal Antibodies, Polyclonal Antibodies, and Other Products
2) Source Types: Mammalian and Microbial
3) Scale of Operation: Preclinical, Clinical, and Commercial
4) End Users: Biopharmaceutical Companies, Research Laboratories, and Other End Users
Further sub-segments include:
- Monoclonal Antibodies divided into Therapeutic and Diagnostic types
- Polyclonal Antibodies categorized into Research and Therapeutic varieties
- Other Products covering Bispecific Antibodies, Antibody-Drug Conjugates (ADCs), and Fusion Proteins
This detailed segmentation highlights the market's complexity and the breadth of its applications across research, clinical, and commercial domains.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Leading Companies Enhancing Their Presence in the Antibody Contract Manufacturing Market here
News-ID: 4459722 • Views: …
More Releases from The Business Research Company
Growth Patterns, Segment Analysis, and Competitive Approaches Influencing the Ar …
The arthrogryposis market is poised for significant advancement as growing medical research and technological progress continue to enhance diagnosis and treatment approaches. With an increasing focus on early intervention and personalized care, this market is expected to expand steadily, improving patient outcomes and quality of life over the coming years. Let's explore the current market size, key players, emerging trends, and important segments shaping the future of arthrogryposis management.
Projected Market…
Emerging Sub-Segments Transforming the Apraxia Market Landscape
The apraxia market is on a promising growth trajectory, driven by advancements in therapy techniques and diagnostic tools. With increasing awareness and technological progress, this sector is set to undergo significant expansion in the coming years. Below is a detailed overview of the market size, key players, trends, and segments shaping its future.
Expected Growth and Market Size Outlook for the Apraxia Market
The apraxia market is projected to experience substantial…
Competitive Landscape: Key Market Leaders and Emerging Participants in the Aplas …
Aplastic anemia is gaining increasing attention as advancements in medical science open new possibilities for treatment and management. With ongoing research and innovation driving progress, the market for aplastic anemia therapies is expected to witness significant growth in the coming years. Let's explore the market's forecasted value, the key players involved, emerging trends, and the main segments shaping this healare sector.
Projected Market Size and Growth Outlook for Aplastic Anemia
The…
Key Factors and Emerging Trends Shaping the Antiphospholipid Syndrome Treatment …
The antiphospholipid syndrome treatment market is poised for significant expansion in the coming years, driven by advancements in medical research and evolving therapeutic strategies. As new technologies and patient care approaches emerge, this market is set to experience remarkable growth and transformation up to 2030.
Antiphospholipid Syndrome Treatment Market Size and Growth Outlook
The market for antiphospholipid syndrome treatments is projected to reach a substantial $88.91 billion by 2030, growing at…
More Releases for Manufacturing
Grain Bins Market Is Going to Boom | Sukup Manufacturing Co. • Meridian Manufa …
The latest study by Coherent Market Insights, titled "Grain Bins Market Size, Share & Trends Forecast 2026-2033," offers an in-depth analysis of the global and regional dynamics shaping this rapidly evolving industry. This comprehensive report highlights the competitive landscape, key market segments, value chain analysis, and emerging technological and regulatory trends expected between 2026 and 2033. The report provides actionable insights for business leaders, policymakers, investors, and new market entrants…
Manufacturing the Future: Exploring the In-Space Manufacturing Market
Rapid improvements in space technology have created new opportunities for in-space production, transforming the space sector. The in-space manufacturing sector is expanding rapidly as space agencies and private companies investigate ways to manufacture products and structures in space. According to MarketsandMarkets' thorough market research analysis, the worldwide in-space manufacturing market is predicted to expand significantly in the next years. In this blog article, we will evaluate the recent trends and…
Global Miscellaneous Market by Types (Gasket, Packing, and Sealing Device Manufa …
The global Miscellaneous market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
Global Miscellaneous Market overview
Miscellaneous Market research report offers great insights into the market and consumer data and their interpretation through various figures and graphs.
Miscellaneous markets have experienced significant growth in recent years. The main reason for this is the increasing…
Smart Factory Transforming from “Manufacturing” to “Intelligent Manufactur …
The concept of “Industry 4.0” was officially announced by the German government in 2013 at the Hannover Messe. Since then, its influence has taken the world by storm. From steam mechanization to power automation to data informatization, the Industry 4.0, driven by “intelligentization”, will completely subvert the expectations, changing perceptions of productivity and production relations in the traditional manufacturing industry by way of qualitative change – an immortal monument, perhaps,…
Digital Meter Market 2017 - Al-Jon Manufacturing, Environmental Manufacturing, H …
The Global Digital Meter Market 2017 Industry Research Report focused on global and regional market, major manufacturers, as well as the current state of the Digital Meter industry. First, "Global Digital Meter Industry 2017" report analyzed the basic scope of this industry like definition, specification, classification, application, industry policy, news analysis and Digital Meter industry chain structure.
Major Companies Covered in this report:-
Al-Jon Manufacturing
Heitman Laboratories
Kws Manufacturing Company
Kmb Systems
Obvius Holdingd Llc
Lubecorp Manufacturing
Quadlogic…
Competitive Segmentation of Global Mixed-mode Manufacturing Market 2016 Industry …
The market research report titled Mixed-mode Manufacturing Market Research Report 2016 provides a detailed overview of the global Mixed-mode Manufacturing market, in terms of crucial market factors such as the demand drivers, challenges, market segments, key companies, and the recent market trends. The quantitative and the qualitative information presented in this research study is based on primary and secondary sources of information. Moreover, much of the information contained in this…
